Pharmaceutical validation as a process of improving the quality of antineoplastic treatment

Journal of Oncology Pharmacy Practice

Volumn 11, Issue 2, 2005, Pages 45-50

  Serrano Fabiá, Amparo ^a   Cavero Rodrigo, Elisa ^a   Marí, Asunción Albert ^a   Almenar Cubells, Daniel ^a   Jiménez Torres, N Victor ^a,b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Antineoplastic treatment; Medication errors; Pharmaceutical validation; Preparation; Prescription; Standardization

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; HEALTH CARE QUALITY; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MALE; MEDICATION ERROR; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; STANDARDIZATION; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HEMATOLOGY; HOSPITAL UNITS; HUMANS; INPATIENTS; MALE; MEDICAL ONCOLOGY; MEDICATION ERRORS; MIDDLE AGED; PATIENT CARE; PHARMACEUTICAL SERVICES; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS; TOTAL QUALITY MANAGEMENT;

EID: 23644446664     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1191/1078155205jp156oa     Document Type: Article

References (23)

1. American Society of Hospital Pharmacist. ASHP guidelines on preventing medication errors with antineoplastic agents. Am J Health- Syst Pharm 2002; 59: 1648-68.
2. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGram-Hill, 1998.
3. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001; 41: 192-99.
4. Jiménez Torres NV, Font Noguera I, Climente Martí M. Problemas farmacoterapéuticos: Guía para su prevención y resolución. Fifth edition. Valencia: AFAHPE 2003: 105-134.
5. Schneider PJ, Gift MG, Lee YP, et al. Cost of medication-related problems at a university hospital. Am J Health Syst Pharm 1995; 52: 2415-18.
6. Overhage JM, Lukes A. Practical, reliable, comprehensive method for characterizing pharmacists' clinical activities. Am J Health Syst Pharm 1999; 56: 2444-50.
7. Beckwith MC, Tyler LS. Preventing medication errors with antineoplastics agents, Part I. Hosp Pharm 2002; 35: 511-25.
8. Limat S, Drouhin JP, Demesmay K, et al. Incidence and risk factors of preparation errors in a centralized cytotoxic preparation unit. Pharm World Sci 2001; 23: 102-106.
9. American Society of Hospital Pharmacist. ASHP guidelines on preventing medication errors with antineoplastic agents. Am J Health- Syst Pharm. 2002; 59: 1648-68.
10. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA 1995; 274: 35-43.
11. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995; 274: 29-34.
12. Bates DW, Teich JM, Lee J, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999; 6: 313-21.
13. Schneider PJ. Measuring medication safety in hospitals. Am J Health-Syst Pharm 2002; 59: 2330-32.
14. Beer J, Dobish R, Chambers C. Physician order entry: a mixed blessing to pharmacy? J Oncol Pharm Practice 2002; 8: 119-26.
15. Lesar TS. Practitioner intervention-reporting systems for measuring the quality of drug use. Am J Health Syst Pharm 2002; 59: 2320-22.
16. Keely JL. Pharmacist scope of practice. American College of Physicians-American Society of Internal Medicine. Ann Intern Med 2002; 136: 79-85.
17. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282: 267-70.
18. Womer RB, Tracy E, Soo-Hoo W, et al. Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains. J Clin Oncol 2002; 20: 4705-12.
19. Miller CL, Topping DL, Faris RJ, Ashby DM. Describing drug-related problems in an Inpatient Oncology setting. 37th Annual ASHP Midyear Clinical Meeting and Exhibits. Atlanta. December 2002 (abstract).
20. Alcázera MA, Pérez-Landeiro A, Pandero MI, et al. Errors detected in the prescription of antineoplastic agents and their severity level. Eur Hosp Pharm 2001; 7: 20-23.
21. Aguirrezabal A, Alvarez M, Yurrebaso MJ, et al. Detección de errores en la prescripción de quimioterapia. Farm Hosp 2003; 27: 219-223.
22. Vanderbroncke J, De Cock P, Robays H. Influence of a computerized program on the quality of prescribing and preparing cytotoxic drugs. J Oncol Pharm Practice 2004; 10: 61.
23. The National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP). Use of medication errors rates to compare health care organizations is of no value. Retrieved 15 May 2003, from http://www.nccmerp.org/.